Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-01-29 @ 5:07 AM
Study NCT ID:
NCT02581202
Status:
COMPLETED
Last Update Posted:
2019-06-06
First Post:
2015-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-21
Start Date Type:
None
Primary Completion Date:
2017-05-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-19
First Submit QC Date:
None
Study First Post Date:
2015-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-23
Results First Submit QC Date:
None
Results First Post Date:
2019-03-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-22
Last Update Post Date:
2019-06-06
Last Update Post Date Type:
ACTUAL